4-Chloro-6,7-dihydro-5H-cyclopenta[b]pyridin-7-yl acetate

Catalog No. :
ACQXKC240
CAS No. :
945666-87-5
Molecular Formula :
C10H10ClNO2
Molecular Weight :
211.65

IUPAC Name:4-chloro-6,7-dihydro-5H-cyclopenta[b]pyridin-7-yl acetate

4-Chloro-6,7-dihydro-5H-cyclopenta[b]pyridin-7-yl acetate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$273.00Login to see priceInquiryInquiry
250mg95%$435.00Login to see priceInquiryInquiry
1g95%$1094.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-Chloro-6,7-dihydro-5H-cyclopenta[b]pyridin-7-yl acetate
IUPAC Name4-chloro-6,7-dihydro-5H-cyclopenta[b]pyridin-7-yl acetate
MDL No.MFCD11112163
Molecular FormulaC10H10ClNO2
Molecular Weight211.65
SMILESCC(OC1CCC2=C(Cl)C=CN=C21)=O
InChI KeyMNKSKFGPLLEKNZ-UHFFFAOYSA-N
Synonym5H-Cyclopenta[b]pyridin-7-ol, 4-chloro-6,7-dihydro-, 7-acetate;4-chloro-6,7-dihydro-5H-cyclopenta[b]pyridin-7-yl acetate;4-chloro-6,7-dihydro-5H-cyclopenta[b]pyridin-7-yl acetate ISO 9001:2015 REACH;4-chloro-6,7-dihydro-5H-Cyclopenta[b]pyridin-7-ol 7-acetate
CAS No.945666-87-5
PubChem CID57356830

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACQXKC240 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACEOGB318 route compound structure diagram
    ACEOGB318126053-15-4 In Stock
  2. Then
  3. ACQXKC240 route product structure diagram
    ACQXKC240945666-87-5
Inquiry

2. ACQXKC240 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACEOGB318 route compound structure diagram
    ACEOGB318126053-15-4 In Stock
  4. Then
  5. ACQXKC240 route product structure diagram
    ACQXKC240945666-87-5
Inquiry

Comments (0)